Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

VitaNova Life Sciences (YJGJ) EPS (Basic) (2018 - 2026)

VitaNova Life Sciences (YJGJ) has disclosed EPS (Basic) for 8 consecutive years, with $0.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) rose 9.69% year-over-year to $0.0, compared with a TTM value of $0.03 through Oct 2025, up 50.0%, and an annual FY2025 reading of $0.03, up 200.0% over the prior year.
  • EPS (Basic) was $0.0 for Q4 2025 at VitaNova Life Sciences, up from -$0.0 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.03 in Q2 2025 and bottomed at -$0.01 in Q4 2023.
  • Average EPS (Basic) over 5 years is $0.0, with a median of $0.0 recorded in 2022.
  • The sharpest move saw EPS (Basic) plummeted 2357.3% in 2023, then skyrocketed 1438.94% in 2024.
  • Year by year, EPS (Basic) stood at $0.0 in 2021, then crashed by 82.67% to $0.0 in 2022, then tumbled by 2357.3% to -$0.01 in 2023, then surged by 113.05% to $0.0 in 2024, then rose by 9.69% to $0.0 in 2025.
  • Business Quant data shows EPS (Basic) for YJGJ at $0.0 in Q4 2025, -$0.0 in Q3 2025, and $0.03 in Q2 2025.